More lessons on patent amendment

9 March 2015
6 years after our “Lessons about patent amendment” post the Federal Court has handed down another decision in the same proceeding (Apotex v Les Laboratories Servier (No 4) [2015] FCA) about amending a patent under s 105 of the Patents Act.
Read on

The CGK: Our review of Australia’s patent cases for 2012

2 May 2013
We are excited to announce the launch of ‘The CGK’ - our review of Australia’s patent cases for 2012. This is the 10th edition of our annual patent review. The CGK examines the most important patent decisions handed down in 2012, including the Full Court’s decisions in SNF (Australia) Pty Ltd v Ciba Specialty Chemicals Water Treatments Ltd and Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (No 2) (as well as Apotex’s successful application for special leave to appeal to the High Court in the latter proceeding) and the Federal Court’s use of innovative trial procedures such as in Britax Childcare Pty Ltd v Infa-Secure Pty Ltd. Click here to read The CGK.
Read on

Selection patents – a developing area of law?

29 April 2013
Apotex recently failed in its attempt to have Eli Lilly's patent covering antipsychotic drug Zyprexa revoked by the Federal Court. In his judgment (Eli Lilly v Apotex), Justice Middleton considered two relatively fresh issues – the proper approach to ‘selection patents’, and the significance of differences in the naming of chemical formulae.
Read on